Leaflet ULDIULAN 12.5mg tablets
Indicated for: hypertension
Route of administration: oral
Substance: chlorthalidone (diuretic)
ATC: C03BA04 (Cardiovascular system | Low-ceiling diuretics, excluding thiazides | Sulfonamides, plain)
Dose adjustment may be needed in kidney disease.
May lower blood pressure and increase the risk of falls.
Periodic laboratory tests may be required during treatment.
This medicine may change blood electrolyte levels.
Chlorthalidone is a thiazide diuretic used for the treatment of hypertension and edema associated with heart failure, liver cirrhosis, or kidney disorders. It works by increasing the excretion of sodium and water, thereby reducing blood volume and blood pressure.
The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and undergo regular medical check-ups to monitor blood pressure and kidney function.
Patients should be aware of potential side effects, such as dizziness, electrolyte imbalances, or muscle cramps. It is important to inform the doctor of any unusual symptoms.
Common side effects include dizziness, hypokalemia, hyponatremia, and fatigue. In rare cases, severe reactions such as pancreatitis or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about ULDIULAN 12.5mg
- Substance: chlorthalidone
- Date of latest medicines list: 01-03-2023
- Product code: W69401001
- Concentration: 12.5mg
- Pharmaceutical form: tablets
- Quantity: 10
- Product type: Generic medicine
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for chlorthalidone
- 12.5mg
- 25mg
- 50mg